Literature DB >> 22442608

Expression of p53 protein and ki-67 antigen in oral premalignant lesions and oral squamous cell carcinomas: An immunohistochemical study.

S Humayun1, V Ram Prasad.   

Abstract

AIM: To study expression of p53 protein and ki-67 antigen in normal, non-dysplastic, dysplastic, premalignant and malignant lesions of the oral mucosa.
MATERIALS AND METHODS: The standard immunohistochemical method along with MIB-1 and DO-7; DAKO antibodies was used to study the expression of p53 and ki-67 in paraffin-embedded tissue specimens.
RESULTS: All samples studied showed positive staining for p53 and ki-67. Only one case each from leukoplakia and oral squamous cell carcinoma (OSCC) groups showed negative staining for ki-67. The staining was confined to basal layer in most of the cases except OSCC in which it was seen in all layers. The intensity of staining was moderate to intense. The percentage of p53-positive cells in normal mucosa was 15-25% which was increased to 95% in malignant mucosa. Statistical analysis revealed that the expression of p53 and ki-67 increases as normal oral mucosa becomes dysplastic and undergoes malignant transformation.
CONCLUSION: These results emphasize the potential use of p53 protein and ki-67 antigen as markers of malignant transformation and carcinogenesis in oral premalignant lesions, conditions and OSCC, respectively; and in future they may serve as prognostic tools in the early detection of malignant transformation in oral premalignant lesions and conditions.

Entities:  

Keywords:  Immunohistochemistry; ki-67 antigen; oral leukoplakia; oral submucous fibrosis; p53 protein

Year:  2011        PMID: 22442608      PMCID: PMC3304220          DOI: 10.4103/0975-5950.85852

Source DB:  PubMed          Journal:  Natl J Maxillofac Surg        ISSN: 0975-5950


INTRODUCTION

Oral cancer is the most common cancer and constitutes a major health problem in developing countries, representing the leading cause of death. Although representing 2-4% of the malignancies in the West, this carcinoma accounts for almost 40% of all cancers in the Indian subcontinent.[1] A key factor in the lack of improvement in prognosis over the years is the fact that a significant proportion of oral squamous cell carcinoma (OSCC) are not diagnosed or treated until they reach an advanced stage. The prognosis for patients with OSCC that is treated early is much better, with 5-year survival rates as high as 80%.[1] In addition; the quality of life also improves after early treatment. A significant proportion of OSCC develop from premalignant lesions such as leukoplakia and oral submucous fibrosis (OSMF). Histological examination of tissue remains the gold standard for diagnosis and identification of malignant oral lesions. Molecular level changes in the lesion occur before clinical and histopathological changes.[1] Identification of high-risk oral premalignant lesions and intervention at premalignant stages could constitute one of the keys in reducing the mortality, morbidity and cost of treatment associated with OSCC. Leukoplakia is a common lesion of the oral mucosa, which is defined as a white patch or plaque that cannot be characterized clinically or pathologically as any other disease. The percentage of leukoplakias that progress to invasive SCC is accepted to be directly related to the severity of the dysplastic changes and it ranges from 5 to 43%.[2] OSMF is a high-risk precancerous condition characterized by changes in the connective tissue fibers of the lamina propria and deeper parts leading to stiffness of the mucosa and restricted mouth opening. OSMF has been reported almost exclusively among Indians and Asians. Malignant transformation rates as high as 7.6% over a 10-year period have been reported.[3] The etiology of premalignant lesions is generally accepted to be multifactorial, with tobacco and alcohol being reported as important cofactors in transition from premalignancy to malignancy. Consumption of tobacco and betel quid (betel leaf-coated with slaked lime and wrapped around areca nut plus some spicy ingredients) can cause genetic and molecular alterations in clinically distinct oral premalignant lesions and conditions.[3] Molecular biological markers have been suggested to be of value in the diagnosis and prognostic evaluation of precancerous lesions. Markers of proliferation, epithelial differentiation and genomic markers could potentially be good candidates for improving the prognostic evaluation of precursors of oral cancer. As yet, one or panel of molecular markers has not been determined that allows for a prognostic prediction of oral precancer. However, these new markers could be considered complementary to conventional prognostic evaluation.[4]

P53 protein

P53 is the name of the tumor suppressor gene located on short arm (p) of chromosome 17, as well as the protein encoded by this gene (TP53). The p53 protein consists of 393 amino acids and comprises four regions with different functions.[5] The normal p53 protein (called wild type) has a very short half life therefore can be hard to detect in normal tissues. However, the protein can remain in the tissues longer due to mutations, or a defect in the degradation pathway or by binding to other proteins.[5] The physiological function of p53 protein is that of preventing accumulation of genetic damage in cells either by allowing for repair of the damage before cell division or by causing death of the cell. The mutant p53 protein is normally not active, thus leading to the loss of the tumor suppressor function of the protein.[4] The most common p53 alteration is a point mutation confined primarily to exons 5 to 8. The alterations of p53 impair the ability of the cells to repair and undergo apoptosis in response to DNA damage which will lead to uncontrolled cell growth.[6]

Ki-67 antigen

Ki-67 is a cell cycle associated human nuclear protein present in peri-chromosomal region, the expression of which strictly associated with cell proliferation and which is widely used in pathology as a proliferation marker to measure the growth fraction of cells in human tumors.[7] The estimated half life of ki-67 antigen is 60-90 minutes. The ki-67 antigen starts to be expressed in the S phase, progressively increasing through S and G2 phases and reaching a plateau at mitosis. After cell division, the cells return to G1 with a stock of ki-67 antigen, whose level decreases rapidly during this phase.[28] The purpose of this study was to investigate the expression of p53 protein and ki-67 antigen in normal oral mucosa, OSMF, oral leukoplakia with or without dysplasia and OSCC using immunohistochemistry, and to clarify the correlation of the expression of these cell cycle regulatory proteins and clinico-pathological factors.

MATERIALS AND METHODS

Sample collection and preparation

The samples were collected from 14 cases reported to the Department of Oral and Maxillofacial Surgery, Government Dental College and Hospital, Hyderabad, which consisted of four patients with OSCC, four patients with oral leukoplakia, four patients with OSMF and two patients with normal oral mucosa as controls. Demographic details were recorded for all patients and included age, sex and personal history about alcohol consumption, tobacco chewing or smoking and other chewing habits. The age of the patients ranged from 18 to 75 years (mean age, 40.5 years). Among all 14 patients, 13 were male and only 1 was female. Tobacco or betel quid or both chewing habits were present in all patients except one case with leukoplakia. Normal controls were selected based on no history of alcohol, tobacco or betel quid use. Both premalignant lesions and conditions were selected based on the absence of any invasive OSCC. All patients were healthy with no systemic disease except two cases (one had renal calculi and the other had systemic hypertension). The patients with disseminated disease, loco-regional recurrence, other serious illness, or with poor general condition were not included in the present study. All patients were from medium socioeconomic group except three cases of oral cancer who belonged to low socioeconomic group. A detailed clinical, radiological and histopathological data for each patient was also recorded. All the 14 patients were subjected to incisional biopsy and the soft tissue specimens were routinely fixed in 10% formalin (24-48 hours) and processed in the laboratory, in Pathology Department, Krishna Institute of Medical Sciences, Secunderabad. For all cases the clinical diagnosis was confirmed histopathologically after hematoxylin and eosin staining of archival specimens. OSCC specimens were histologically graded as well differentiated (four cases), moderately differentiated, and poorly differentiated SCCs according to the differentiation of cells and the resemblance of neoplastic cells to that of epithelial cells. Excluding dysplastic features, the premalignant lesions (leukoplakia) were histologically classified into proliferative (one case) (hyperplastic) and non-proliferative (three cases) (hyperkeratosis) subtypes based on the presence of basal cell hyperplasia, proliferation and elongation of rete pegs, and thickening of entire epithelium.[9] The premalignant condition (OSMF) cases were clinically graded as grade II (four cases) based on extent of mouth opening and palpable fibrous bands. The normal controls were taken from buccal mucosa of age-matched healthy individuals without any deleterious chewing habit. Tissues showing dysplastic features limited to basal and supra basal layers were graded as mild dysplasia (four cases), involving basal layer till the mid portion of the spinous layer as moderate dysplasia and alterations from basal layer to a level above the mid-portion of the spinous layer as severe dysplasia.[10]

Immunohistochemistry

The tissue sections were cut to 3-4 μ thickness on APES (3-amino propyl triethoxy silane) coated slides and the slides were marked. The slides were left in hot air oven at 65°C for 30 minutes and later dipped and deparaffinized in xylene for 10 minutes (three changes). Then slides were rehydrated through graded alcohols (two changes) and running tap water. The slides were not allowed to dry at any point. Antigen retrieval was performed by placing the slides in citrate buffer at 95°C for 5 minutes (4-5 times). Then the slides were cooled to room temperature and next steps of staining were performed in a humid chamber. After washing the slides with wash buffer (PBS, phosphate buffer solution), peroxide block (0.3% hydrogen peroxide in methanol) was applied for 10 minutes. Then power block (supplied by the manufacturer) is applied for 10 minutes and primary antibody [monoclonal mouse anti ki-67 antibody (MIB-1) for ki-67 and antihuman p53 protein (DO-7; DAKO) for p53] was added and incubated for 10-30 minutes. Again the slides were washed and super enhancer (secondary antibody) was applied for 30 minutes. Then poly HRP (horse radish peroxidase enzyme polymer) reagent was applied for 30 minutes and the slides were washed in wash buffer for 5 minutes (two times). Di-acetyl bromo acetic acid (DAB) was added to the slide for 3-4 minutes and washed with buffer. The slides were dipped in Mayor's hematoxylin for less than a minute and washed in running tap water. Finally the slides were dehydrated in ascending grades of alcohol and then to xylene and mounted with diphenylene phthalate xylene.

Evaluation of staining

The intensity of immunohistochemical staining was graded based on subjective evaluation of color exhibited (brown color) by antigen, antibody and chromogen complex as: negative (-, no color), mild (+, light brown color), moderate (++, dark brown color) or intense (+++, very dark brown color). The distribution of staining was graded as confined only to basal layer, both basal and supra basal layers, and all layers of the epithelium. Only nuclear staining of epithelial cells was observed, and the nuclei with clear brown color, regardless of staining intensity, were regarded as positive. The pattern of expression was also analyzed semi quantitatively by counting the number of positive cells per 100 basal or parabasal cells and was recorded as percentage. The percentage of positive cells was scored as: 0 = 0-5%; 2 = 6-25%; 4 = 26-60%; 6 = 61-99%. The area with maximum number of positive cells was considered in each section.[9] Known positive immunostaining slides were used as positive controls. All the samples histopathologically and immunohistochemically studied were categorized into four groups such as normal oral mucosa (normal control) group, OSMF group, oral leukoplakia group and OSCC group. The parameters used to analyze the expression of both p53 protein and ki-67 antigen are: 1) pattern or distribution of expression in the epithelial layers; 2) intensity of staining in each slide; 3) the percentage of positive cells or labeling index (LI).

Statistical analysis

The percentage of positive cells or the LI for each slide in each group was calculated by dividing the number of positive cells by the total number of cells counted in the slide. Mean LI and standard deviation was calculated for all groups using descriptive analysis. As the scores were not continuous variables, statistical analysis was done using non-parametric methods. The Kruskal Wallis one-way ANOVA test was done to find out if there is any significant difference of mean LI between the groups for each antibody. In addition to one way ANOVA, pair wise comparison of LI of p53 between the groups were made using Mann-Whitney U test. LIs of p53 and ki-67 for all groups were compared to find out relationship if any by using Spearman rank correlation test. χ2 test was used to find out if there is any association between pattern or distribution, LI and intensity of staining for each antibody between the groups. P-value was considered significant where it was less than 0.05.

RESULTS

The results of immunohistochemical analysis of p53 and ki-67 expression are summarized in Table 1. The expression of each protein in each group is analyzed and interpreted as follows:
Table 1

IHC staining details of p53 and ki-67 in all groups

IHC staining details of p53 and ki-67 in all groups

P-53

Normal oral mucosa

Staining was nuclear and was confined to the basal layer of cells [Figure 1]. The intensity of staining was moderate and intense in 2 cases respectively. The mean LI was 20 with a standard deviation of 5.77.
Figure 1

Immunohistochemical expression of p53 in normal oral mucosa

Immunohistochemical expression of p53 in normal oral mucosa

Oral submucous fibrosis

All OSMF cases showed only basal layer expression and intense (+++) nuclear staining was seen in all cases except one which has moderate intensity (++) [Figure 2]. The LI of this group ranges from 80 to 95%. The mean LI was 90 with a standard deviation of 7.07 and this is very high than normal control group (20 ± 5.77).
Figure 2

Immunohistochemical expression of p53 in oral submucous fibrosis

Immunohistochemical expression of p53 in oral submucous fibrosis

Oral leukoplakia

Staining was nuclear and all leukoplakia cases had mild dysplastic features with only basal layer expression of p53 except one slide which has supra basal expression [Figure 3]. All the slides were stained moderately (++) except the proliferative type which was stained intense (+++). The LI ranges from 55 to 95%. The mean LI was 75 with a standard deviation of 16.83 [Table 2].
Figure 3

Immunohistochemical expression of p53 in oral leukoplakia

Table 2

Comparison of four groups with respect to labeling index of p53 by Kruskal Wallis one-way ANOVA test

Immunohistochemical expression of p53 in oral leukoplakia Comparison of four groups with respect to labeling index of p53 by Kruskal Wallis one-way ANOVA test

OSCC

All cases showed staining in all layers of epithelium [Figure 4]. The intensity ranged from moderate (++) to intense (+++). Two cases were stained moderate and the other two stained intense. The LI ranged from 40 to 95%. The mean LI was 66.25 with a standard deviation of 25.62 [Table 2]. The mean LIs of pathological groups were very high than the normal control group [Table 2].
Figure 4

Pattern of expression of p53 in oral squamous cell carcinoma

Pattern of expression of p53 in oral squamous cell carcinoma The Kruskal Wallis one-way ANOVA test showed that there was a significant difference of mean LI (P-value 0.0175) between the groups (normal, OSF, leukoplakia and OSCC) [Table 2]. Mann-Whitney U test showed a significant mean LI difference (P-value 0.02) when normal mucosa group compared with other groups, but no significant mean LI difference was observed when OSMF, leukoplakia and OSCC groups compared with each other (P-value 0.19 and 0.56) [Table 3].
Table 3

Pairwise comparison of four groups with respect to labeling index of p53 by Mann-Whitney U test

Pairwise comparison of four groups with respect to labeling index of p53 by Mann-Whitney U test χ2 test showed significant staining pattern relationship (P-value 0.0043) and LI relationship (P-value 0.0033) between the four groups, but no significant relationship was found in the staining intensity among all groups (P-value 0.57) [Table 4–6].
Table 4

Comparison of four groups with respect to labeling index of ki-67 by Kruskal Wallis one-way ANOVA test

Table 6

Distribution of cases according to groups and intensity of staining (p53)

Comparison of four groups with respect to labeling index of ki-67 by Kruskal Wallis one-way ANOVA test Distribution of cases according to groups and pattern of staining for p53 antibody Distribution of cases according to groups and intensity of staining (p53)

KI-67

All samples showed positive staining with variable number of positive cells except two cases, one each from leukoplakia and OSCC groups. Staining was intense and was seen only in the basal layer of cells [Figure 5]. The mean LI for this group was 30 with a standard deviation of 23.09 [Table 7].
Figure 5

Immunohistochemical expression of ki-67 in normal oral mucosa

Table 7

Distribution of cases according to groups and labeling index of p53

Immunohistochemical expression of ki-67 in normal oral mucosa Distribution of cases according to groups and labeling index of p53 These cases showed only basal layer expression and intense (+++) nuclear staining [Figure 6]. The LI ranges from 15 to 95%. The mean LI was 53.75 with a standard deviation of 39.66 [Table 7].
Figure 6

Immunohistochemical expression of ki-67 in oral submucous fibrosis

Immunohistochemical expression of ki-67 in oral submucous fibrosis Only three cases showed basal expression [Table 8]. One case in this group showed negative expression for ki-67. The staining intensity ranged from mild (+) to intense (+++) and the LI ranged from 3 to 45%. The mean LI was 35.75 with a standard deviation of 44.52 [Figure 7].
Table 8

Distribution of cases according to groups and pattern of staining for ki-67 antibody

Figure 7

Immunohistochemical expression of ki-67 in oral leukoplakia

Distribution of cases according to groups and pattern of staining for ki-67 antibody Immunohistochemical expression of ki-67 in oral leukoplakia Only three cases positive staining for ki-67 antibody. One case was negative for ki-67 antibody. The staining intensity was intense (+++) in all positive cases [Table 9]. The pattern of expression was basal and suprabasal in one case and the rest of two cases exhibited positive cells in all layers [Figure 8]. The LI ranged from 20 to 50%. The mean LI was 25 with a standard deviation of 20.82.
Table 9

Distribution of cases according to groups and intensity of staining (ki-67)

Figure 8

Pattern of expression of ki-67 in oral squamous cell carcinoma

Distribution of cases according to groups and intensity of staining (ki-67) Pattern of expression of ki-67 in oral squamous cell carcinoma When all the four groups were compared for mean LI (ki-67) by the Kruskal Wallis one-way ANOVA test there was no statistically significant mean difference (P-value 0.70) between the groups (normal, OSF, leukoplakia and OSCC). χ2 test showed significant staining pattern relationship (P-value 0.04) and LI relationship (P-value 0.021) between the four groups, but no significant relationship was found in the staining intensity among all groups (P-value 0.35) [Table 8–10].
Table 10

Distribution of cases according to groups and labeling index of ki-67

Distribution of cases according to groups and labeling index of ki-67 When the percentage of positive cells (LI) for p53 and ki-67 are compared between all four groups by Spearman rank correlation test positive but statistically non-significant relationship was observed [Table 11].
Table 11

Correlation between percentage of positive cells (labeling index) of p53 and ki-67

Correlation between percentage of positive cells (labeling index) of p53 and ki-67

DISCUSSION

Mutations in the p53 gene are the most common genetic changes observed in OSCCs. These mutations lead to uncontrolled cell proliferation, resulting in further genetic abnormalities and finally in malignancy. Therefore, the nature of the p53 gene and the proliferative status of a cell are closely linked and the loss of this linkage is one of the main causes of tumor formation and is considered to be an early event in this process. To analyze the proliferative status of a cell or tissue Ki-67 marker is reliable and widely used. It recognizes a proliferation-related nuclear antigen present at all phases of cell cycle except G0.[9] In the present study all the normal control tissues (oral mucosa) unrelated to any deleterious chewing habit exhibited positive p53 expression at the basal layer in consistent with other studies.[31112] The possible explanation is that genotoxic stress, caused by a physical, chemical or microbiological agent that commonly acts in the oral cavity, may lead to p53 accumulation in these epithelial cells for physiological response.[3] The other possibility for this positive expression may be defect in the degradation pathway or binding of p53 protein to other proteins such as certain DNA virus-encoded proteins.[5] All the samples of normal mucosa showed positive staining with ki-67 in basal layer of epithelium similar to p53; this could be due to the physiological proliferative activity in the basal cell layer. The mean LI of ki-67 (30.0 ± 23.09) is higher than p53 (20.0 ± 5.77) as one sample of normal mucosa showed high ki-67 expression which could be due to high proliferative activity in the basal layer secondary to chronic irritation or any physical stress. In this study, males were more affected with the premalignant and malignant lesions than females because traditionally males are more likely to display oral habits such as tobacco smoking and betel quid chewing. It was found that oral premalignant lesions affected more commonly younger patients (mean age-31.5) and OSCC developed in older individuals (mean age-63.25) which was also confirmed by previous studies. Most of the cases in this study exhibited dysplastic and neoplastic lesions on buccal mucosa as the common site which is more or less related with the habit of tucking the betel quid into the buccal area while chewing. The strong relation found between the combination of betel quid chewing and smoking habit in leukoplakia and betel quid or gutkha chewing in OSMF are considered to play a critical role in the initiation, progression and immunological aspects of the development of oral premalignant lesions and conditions. The present study revealed that the p53 expression in premalignant lesions and conditions was significantly associated with the personal habits. Increased p53-positive cells were detected in patients with both betel quid chewing and smoking habits which is in contrary to the study of Yan et al,[13] which revealed that Taiwanese patients without a betel quid chewing habit had a higher rate of p53 over expression than heavy chewers. In OSMF cases, p53 expression although limited to basal layer, was very high when compared to normal control group which is consistent with the study of Win SS et al.[3] This indicates the possibility of mutations in p53 gene in the development and progression of OSMF. The most common culprit, areca nut products have a high copper content, which suggest a copper-mediated etiopathogenic mechanism for genetic aberration found in OSMF by means of binding with p53 gene.[314] All the leukoplakia samples showed moderate p53 expression in the basal layer similar to OSMF group except one case which expressed even in supra basal layer also. Cruiz IB et al,[15] in their study observed that 86% of premalignant lesions that showed p53 expression above the basal layer developed into SCC. They stated that p53 expression above the basal cell layer is an early event in oral carcinogenesis. Huang WX et al,[16] in their study observed that there is a significant predilection for basal and supra basal staining pattern with the progression of lesion towards malignancy compared to strictly basal layer staining in the normal mucosa. The above reports and the present study suggest that the expression of p53 above the basal layer could be an early event in oral carcinogenesis and an indicator of developing carcinoma. The results of p53 expression in oral leukoplakia of the present study are comparable with the other studies.[15-18] Hence, the present study suggests that the expression pattern of p53 is significant in predicting the malignant transformation of oral premalignant lesions and conditions. In the present study, 2 cases of OSMF showed high LI of ki-67 whereas the other two cases expressed low which is indicative of high and low proliferative activity in the OSMF epithelium, respectively. Among all leukoplakia cases one case of proliferative type highly expressed ki-67 marker which was correlating with clinical features. The results of the present study in OSMF and leukoplakia groups showed positive correlation between p53 mutations and proliferative activity (ki-67 expression) of the basal layer only in two samples each from both groups but inverse relation was observed in two samples of OSMF group. Hence, it was difficult to completely analyze the relation between p53 and ki-67 expression in OSMF and leukoplakia groups and further studies may be required using large samples. OSCC samples of this study showed moderate to high p53 expression with a mean LI of 66.25 ± 25.62 which is higher than normal mucosa (20.0 ± 5.77). When all the three pathological groups were compared with normal mucosa by Mann-Whitney U test a significant mean difference in p53 LI was observed which indicates increased expression of p53 as normal mucosa becomes dysplastic and undergoes malignant transformation and this is supported by other reports such as the study of Kannan et al.[9] The LI of p53 expression for normal mucosa samples, leukoplakia and OSCC were comparable with the studies of Abbas et al,[19] Girod et al[20] and Kannan et al.[9] The present study observed that mutant p53 gene is a common event in the development of OSCC which is consistent with the report of Langdon JD et al.[21] The previous studies on p53 expression in oral premalignant lesions and OSCC showed a range of positivity of 35-90% and this finding is also observed in the present study (40-95%). The mean LI of ki-67 expression in four samples of well differentiated OSCC of this study was low (28 ± 20.82) and this is consistent with the study of Fabricio et al[22] which revealed that immunohistochemical assessment of ki-67 showed scarce immunoreactive tumor cells (20 ± 3.2) in well-differentiated OSCC, while the samples of patients from moderately to poorly differentiated OSCC expressed high number of ki-67-positive cells i.e., 47 ± 6.3 and 60.3 ± 2.8, respectively. Hence, the present study suggests that the ki-67 expression in OSCC is significant and useful in predicting histologic grade of differentiation and prognosis of the lesion. In OSCC group of the present study the localization or pattern of expression of p53 and ki-67 markers was in general agreement with each other; however, the mean LI of ki-67 is less than p53, this may be because of negative expression of ki-67 in one sample or due to the selective expression of ki-67 in the late G1, S, M and G2 phases of the proliferating cells which was also observed in the study of Kuratomi et al.[23] A positive and non-significant correlation was observed between LI of p53 and ki-67 which indicates that there is increase or decrease in p53 LI with increase or decrease of ki-67 LI in oral premalignant lesions and OSCC. In conclusion, the significant correlation between progression of oral epithelium from normal to neoplasia and increased expression of these antigens suggest that they may be useful biomarkers of malignant transformation in oral precancerous lesions and conditions and may serve as intermediate points for cancer prevention programmes. However, further immunohistochemical studies on large samples identifying p53, ki-67 and other associated proteins in premalignant lesions along with the mutational analysis are necessary to predict more specifically the development and malignant transformation of these oral lesions.
Table 5

Distribution of cases according to groups and pattern of staining for p53 antibody

  20 in total

Review 1.  Markers of proliferation in normal and leukoplakic oral epithelia.

Authors:  S C Liu; A J Klein-Szanto
Journal:  Oral Oncol       Date:  2000-03       Impact factor: 5.337

2.  Immunohistological evaluation of Ki-67, p63, CK19 and p53 expression in oral epithelial dysplasias.

Authors:  T Takeda; K Sugihara; Y Hirayama; M Hirano; J-I Tanuma; I Semba
Journal:  J Oral Pathol Med       Date:  2006-07       Impact factor: 4.253

3.  Expression of p53 in leukoplakia and squamous cell carcinoma of the oral mucosa: correlation with expression of Ki67.

Authors:  S Kannan; G J Chandran; K R Pillai; B Mathew; K Sujathan; K R Nalinakumary; M K Nair
Journal:  Clin Mol Pathol       Date:  1996-06

4.  Proliferating cell nuclear antigen and Ki67 immunoreactivity in ameloblastomas.

Authors:  Shabnum Meer; Jacqueline S Galpin; Mario Altini; Hedley Coleman; Hasiena Ali
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2003-02

5.  Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.

Authors:  Naglaa Fathy Abbas; Sonia Labib El-Sharkawy; Effat Ahmed Abbas; Marwa Abdel Monem El-Shaer
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2006-06-30

6.  Immunohistochemical expression of Mina53 and Ki67 proteins in human primary gingival squamous cell carcinoma.

Authors:  Keitaro Kuratomi; Hirohisa Yano; Makoto Tsuneoka; Kikuo Sakamoto; Jingo Kusukawa; Masamichi Kojiro
Journal:  Kurume Med J       Date:  2006

Review 7.  Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics.

Authors:  Jesper Reibel
Journal:  Crit Rev Oral Biol Med       Date:  2003

8.  p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.

Authors:  I B Cruz; P J Snijders; C J Meijer; B J Braakhuis; G B Snow; J M Walboomers; I van der Waal
Journal:  J Pathol       Date:  1998-04       Impact factor: 7.996

Review 9.  Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions.

Authors:  Ravi Mehrotra; Anurag Gupta; Mamta Singh; Rahela Ibrahim
Journal:  Mol Cancer       Date:  2006-03-23       Impact factor: 27.401

10.  Cellular profile of the peritumoral inflammatory infiltrate in squamous cells carcinoma of oral mucosa: Correlation with the expression of Ki67 and histologic grading.

Authors:  Fabricio L D Vieira; Beatriz J Vieira; Marco A M Guimaraes; Fernando M Aarestrup
Journal:  BMC Oral Health       Date:  2008-09-02       Impact factor: 2.757

View more
  21 in total

1.  A PIK3CA transgenic mouse model with chemical carcinogen exposure mimics human oral tongue tumorigenesis.

Authors:  Melody T Tan; Jean G Wu; Juan Luis Callejas-Valera; Richard A Schwarz; Ann M Gillenwater; Rebecca R Richards-Kortum; Nadarajah Vigneswaran
Journal:  Int J Exp Pathol       Date:  2020-05-21       Impact factor: 1.925

2.  Predictive value of tissue p53 protein expression and serum p53 antibodies in oral potentially malignant disorders: Relative to oral squamous cell carcinoma.

Authors:  Abbas S Khan; Sajjad Ahmad; Zahoor Ullah; Naveed Sadiq; Mohsina Haq; Ahmareen K Sheikh
Journal:  J Taibah Univ Med Sci       Date:  2021-12-31

3.  Assesment of Correlation of Herpes Simplex Virus-1 with Oral Cancer and Precancer- A Comparative Study.

Authors:  Mayuri Jain
Journal:  J Clin Diagn Res       Date:  2016-08-01

4.  Expression of Ki67 Biomarker in Oral Submucous Fibrosis with Clinico-Pathological Correlations: A Prospective Study.

Authors:  K A Kamala; Sujata R Kanetkar; Kailash D Datkhile; S Sankethguddad
Journal:  Asian Pac J Cancer Prev       Date:  2022-01-01

5.  Estimation of malignant transformation rate in cases of oral epithelial dysplasia and lichen planus using immunohistochemical expression of Ki-67, p53, BCL-2, and BAX markers.

Authors:  G Shailaja; J Vijay Kumar; P V Baghirath; U Kumar; G Ashalata; A Bhargavi Krishna
Journal:  Dent Res J (Isfahan)       Date:  2015 May-Jun

6.  Regulation of p53 during senescence in normal human keratinocytes.

Authors:  Reuben H Kim; Mo K Kang; Terresa Kim; Paul Yang; Susan Bae; Drake W Williams; Samantha Phung; Ki-Hyuk Shin; Christine Hong; No-Hee Park
Journal:  Aging Cell       Date:  2015-07-01       Impact factor: 9.304

7.  Serum vitamin c and iron levels in oral submucous fibrosis.

Authors:  R Guruprasad; Preeti P Nair; Manika Singh; Manishi Singh; Mp Singh; Arpit Jain
Journal:  Indian J Dent       Date:  2014-04

8.  Evaluation of AgNORs in Oral Potentially Malignant Lesions.

Authors:  Karin Berria Tomazelli; Filipe Modolo; Elena Riet Correa Rivero
Journal:  J Oncol       Date:  2015-08-31       Impact factor: 4.375

Review 9.  An overview of the spindle assembly checkpoint status in oral cancer.

Authors:  José Henrique Teixeira; Patrícia Manuela Silva; Rita Margarida Reis; Inês Moranguinho Moura; Sandra Marques; Joana Fonseca; Luís Silva Monteiro; Hassan Bousbaa
Journal:  Biomed Res Int       Date:  2014-06-03       Impact factor: 3.411

10.  DJ-1 Is Upregulated in Oral Squamous Cell Carcinoma and Promotes Oral Cancer Cell Proliferation and Invasion.

Authors:  Shuaimei Xu; Dandan Ma; Rui Zhuang; Wenjuan Sun; Ying Liu; Jun Wen; Li Cui
Journal:  J Cancer       Date:  2016-05-24       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.